| Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... ACS Infectious Diseases 7 (8), 2546-2564, 2021 | 34 | 2021 |
| A stabilized, monomeric, receptor binding domain elicits high-titer neutralizing antibodies against all SARS-CoV-2 variants of concern S Ahmed, MS Khan, S Gayathri, R Singh, S Kumar, UR Patel, SK Malladi, ... Frontiers in immunology 12, 765211, 2021 | 22 | 2021 |
| Unraveling the Role of Silent Mutation in the ω-Subunit of Escherichia coli RNA Polymerase: Structure Transition Inhibits Transcription UR Patel, S Gautam, D Chatterji ACS omega 4 (18), 17714-17725, 2019 | 16 | 2019 |
| Validation of omega subunit of RNA polymerase as a functional entity UR Patel, S Gautam, D Chatterji Biomolecules 10 (11), 1588, 2020 | 15 | 2020 |
| Neutralizing efficacy of encapsulin nanoparticles against SARS-CoV2 variants of concern S Khaleeq, N Sengupta, S Kumar, UR Patel, RS Rajmani, P Reddy, ... Viruses 15 (2), 346, 2023 | 13 | 2023 |
| A highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative elicits high titers of neutralizing antibodies SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... | 1 | 2021 |
| Inhibition and degradation of NRAS with a pan-NRAS monobody M Whaby, G Ketavarapu, A Koide, M Mazzei, M Mintoo, E Glasser, U Patel, ... Oncogene 43 (48), 3489-3497, 2024 | | 2024 |
Dipankar ChatterjiProfessor,Mol.Biophys.Unit,Indian Institute of Science,Bangalore,INDIAVerified email at mbu.iisc.ernet.in
